NasdaqGS - Delayed Quote • USD
Anika Therapeutics, Inc. (ANIK)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
166,662.00
166,662.00
156,236.00
147,794.00
130,457.00
Cost of Revenue
63,574.00
63,574.00
62,660.00
64,851.00
61,431.00
Gross Profit
103,088.00
103,088.00
93,576.00
82,943.00
69,026.00
Operating Expense
128,537.00
128,537.00
112,976.00
101,423.00
83,494.00
Operating Income
-25,449.00
-25,449.00
-19,400.00
-18,480.00
-14,468.00
Net Non Operating Interest Income Expense
2,312.00
2,312.00
654.00
-188.00
-302.00
Other Income Expense
-62,190.00
-62,190.00
--
21,095.00
-13,854.00
Pretax Income
-85,327.00
-85,327.00
-18,746.00
2,427.00
-28,624.00
Tax Provision
-2,660.00
-2,660.00
-3,887.00
-1,707.00
-4,642.00
Net Income Common Stockholders
-82,667.00
-82,667.00
-14,859.00
4,134.00
-23,982.00
Diluted NI Available to Com Stockholders
-82,667.00
-82,667.00
-14,859.00
4,134.00
-23,982.00
Basic EPS
-5.64
--
-1.02
0.29
-1.69
Diluted EPS
-5.64
--
-1.02
0.28
-1.69
Basic Average Shares
14,656.00
--
14,561.00
14,401.00
14,222.00
Diluted Average Shares
14,656.00
--
14,561.00
14,634.00
14,222.00
Total Operating Income as Reported
-87,639.00
-87,639.00
-19,400.00
2,615.00
-28,322.00
Total Expenses
192,111.00
192,111.00
175,636.00
166,274.00
144,925.00
Net Income from Continuing & Discontinued Operation
-82,667.00
-82,667.00
-14,859.00
4,134.00
-23,982.00
Normalized Income
-22,404.89
-22,404.89
-14,859.00
-11,265.35
-12,372.35
Net Interest Income
2,312.00
2,312.00
654.00
-188.00
-302.00
EBIT
-25,449.00
-25,449.00
-19,400.00
-18,480.00
-14,468.00
EBITDA
-11,232.00
-11,232.00
-4,913.00
-4,163.00
-1,004.00
Reconciled Cost of Revenue
63,574.00
63,574.00
62,660.00
64,851.00
61,431.00
Reconciled Depreciation
14,217.00
14,217.00
14,487.00
14,317.00
13,464.00
Net Income from Continuing Operation Net Minority Interest
-82,667.00
-82,667.00
-14,859.00
4,134.00
-23,982.00
Total Unusual Items Excluding Goodwill
-62,190.00
-62,190.00
--
21,095.00
-13,854.00
Total Unusual Items
-62,190.00
-62,190.00
--
21,095.00
-13,854.00
Normalized EBITDA
50,958.00
50,958.00
-4,913.00
-25,258.00
12,850.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,927.89
-1,927.89
--
5,695.65
-2,244.35
12/31/2020 - 5/3/1993
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANGO AngioDynamics, Inc.
5.81
+0.52%
UTMD Utah Medical Products, Inc.
65.92
-0.56%
AZTA Azenta, Inc.
52.18
+1.32%
OSUR OraSure Technologies, Inc.
5.32
+1.14%
TFX Teleflex Incorporated
206.71
0.00%
INFU InfuSystem Holdings, Inc.
8.12
+6.70%
ATRI Atrion Corporation
395.01
-0.99%
MMSI Merit Medical Systems, Inc.
73.78
+0.55%
NYXH Nyxoah S.A.
10.62
-1.30%
RVP Retractable Technologies, Inc.
1.0750
+1.42%